Search results
Wedbush Weighs in on Apellis Pharmaceuticals, Inc.’s FY2025 Earnings (NASDAQ:APLS)
ETF DAILY NEWS· 6 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush dropped their FY2025 EPS estimates for Apellis Pharmaceuticals in a report released on Wednesday, April ...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Expected to Post Q1 2024 Earnings of ($0.83) Per Share
ETF DAILY NEWS· 6 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at Wedbush raised their Q1 2024 earnings per share estimates for Apellis Pharmaceuticals in a note issued to investors ...